# Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery

> **NCT05315479** · PHASE4 · TERMINATED · sponsor: **Baudax Bio** · enrollment: 19 (actual)

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** N1539

## Key facts

- **NCT ID:** NCT05315479
- **Lead sponsor:** Baudax Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-02-24
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Anjeso (N1539) NDA Withdrawn
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05315479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05315479, "Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05315479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*